Not yet recruiting Phase 2-3-4 HVC trials updated since 01/01/2014

[JimmyMose]

All w Daclatasvir;  3 w Sofosbuvir 1 w Asunaprevir
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
Drug: Daclatasvir;   Drug: Sofosbuvir
Phase III Daclatasvir + Sofosbuvir in Cirrhotic Subjects and Subjects Post-liver Transplant
Drug: Daclatasvir;   Drug: Sofosbuvir;   Drug: Ribavirin
Phase III HIV/HCV Co-Infection Daclatasvir (DCV)+ Sofosbuvir (SOF)
Drug: Daclatasvir;   Drug: Sofosbuvir
Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual
Interventions: Drug: Asunaprevir;   Drug: Daclatasvir
4 studies found for:Not yet recruiting | Hepatitis C | Phase 2, 3, 4 | shows only those updated on or after 01/01/2014 as of this post all are phase III  NOTE: you can click Modify this search (to change specific search criteria terms dates etc)

http://clinicaltrials.gov/ct2/results?term=&recr=Not+yet+recruiting&rslt=&type=&cond=Hepatitis+C+&intr=&titles=&outc=&spons=&lead=&id=&state1=&cntry1=&state2=&cntry2=&state3=&cntry3=&locn=&gndr=&phase=1&phase=2&phase=3&rcv_s=&rcv_e=&lup_s=01%2F01%2F2014&lup_e=

As of now no location info is shown nor a site location number  
keep checking updates hopefully it will show locations and  site location number while still Not yet recruiting

you or doc can email: Clinical.Trials (at) bms.com   First line of the email MUST contain NCT# NCT01973049 and Site #.

_____just guessing---the following______
Since site location number is not available right now  you could try NCT#  + Guessing and major city you live within two hour drive
you can try bms (at) clinicaltrials.gov  and include NCT# ___________  not sure about this one at all

It's best probably to go to the trial and read all the information including Eligibility Inclusion/Exclusion Criteria. If you think it applies and a trail might be right contact your hep doctor with the information  NCT#  etc and if they are not aware ask them to look further if they think it might be good for you.  
_________________________________________
NOTE: there are more trial that show recruiting if you Modify this search While some members have said by the time a trial is showing recruiting many are already full but others have said to still try because they may not be full, or for replacements that dropped out etc.

AGAIN PLEASE talk to your medical professional provider, read the details and general information about trials, trial type and then really think if it's right for you.  There are some good reasons not to get on a trial or you may not be able to. For some people, trying to get off label treatment may be a better option.  Taking approved treatment or waiting for new drugs to be approved may be best for you.  My heart and prayers go out especially to those whose options are very limited.    

Another site to check for trials info etc.  
http://www.hcvadvocate.org/community/trials.asp
Downloadable pdf links
PDF How to Evaluate a Clinical Trial

PDF Making Sense of Hepatitis C Research and Medical Literature (Updated December 2013)
plus
Clinical Trials are listed by Pharmaceutical Company at http://hcvadvocate.blogspot.ca/ and updated regularly

Another place to check for trials & info although it main focus is HIV. It covers some related like the Hepatitis C link on the left  look at the top results - that were I first found info on these new trails Some are HVC only and other was both HIV/HVC
http://www.natap.org/

[Faithdove]

Thank you for posting all this info.

[JimmyMose]

More info about Phase III Daclatasvir and Sofosbuvir  and why Bristol-Myers Squibb is the sponsor and not Gilead  

Bristol-Myers looks to rival Gilead for the key to conquering the hep C market
January 14, 2014 | By John Carroll

No matter how hard Bristol-Myers Squibb ($BMY) tried to shame Gilead into pursuing studies for a combination of its hep C drug daclatasvir and the newly approved Sovaldi (sofosbuvir), Gilead Sciences ($GILD) wouldn't budge. Gilead shrugged off critics and insisted on taking a somewhat longer route to pursue its own in-house combo. But with an approval for daclatasvir likely in the near term, Bristol-Myers is stepping up with a plan to go ahead and marry the two therapies in any case--ahead of Gilead's looming application for a combo with ledipasvir.

Read more
http://www.fiercebiotech.com/story/bristol-myers-looks-rival-gilead-key-conquering-hep-c-market/2014-01-14


The locations for the new announced Phase III studies not recruiting in original post yet are not shown yet
You could try a search at http://clinicaltrials.gov/ct2/search/advanced
Daclatasvir  Recruitment: closed Conditions  Hepatitis C   Country state phase II and see if any test site and zip code is listed  Then you could contact the facility and see if you can track down who does the Hepatitis C  trials  and you or preferably you doctor contacts them to provide your info. for consideration for that trial if they are a site or for future trial consideration.